What's different about older people

Toxicology

Volumn 192, Issue 1, 2003, Pages 49-54

  Crome, Peter ^a  

^a KEELE UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Drugs; Medication; Older people

Indexed keywords

ANESTHETIC AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLINESTERASE INHIBITOR; DONEPEZIL; NONSTEROID ANTIINFLAMMATORY AGENT; NOOTROPIC AGENT; PHENAZONE; SIMVASTATIN; VALSARTAN;

AGE DISTRIBUTION; AGED; AGING; ALZHEIMER DISEASE; BINDING AFFINITY; BLOOD TOXICITY; CLINICAL TRIAL; COHORT ANALYSIS; CONFERENCE PAPER; DISEASE SEVERITY; DRUG BINDING; DRUG CLEARANCE; DRUG HALF LIFE; DRUG METABOLISM; HEALTH STATUS; HEART DISEASE; HEART FAILURE; HUMAN; KIDNEY CLEARANCE; LIVER METABOLISM; NEPHROTOXICITY; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR;

EID: 0141679219     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(03)00253-1     Document Type: Conference Paper

References (20)

1. Abou-Hatab, K., Ganeshalingam, K., O'Mahony, M.S., Giurani, F., Patel, S., Woodhouse, K., 2001. The effect of community-acquired pneumonia on plasma esterases in older people, 2002. Euro. J. Clin. Pharmacol. 57, 55-60.
2. Brown B.G., Zhao X.-Q., Chait A., Fisher L.D., Cheung M.C., Morse J.S., Dowdy A.A., Marino E.K., Bolson E.L., Alaupovic P., Frohlich J., Albers J.A. Simvastatin, and naicin, antioxidant vitamins, or the combination for the prevention of coronary disease. New Engl. J. Med. 345:2001;1583-1592.
3. Cohn J.N., Tognoni G. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. New Engl. J. Med. 345:2001;1667-1675.
4. Cornwall J., Corn T.H. Development of pharmacological treatments for Alzheimer-type dementia. J. R. Soc. Med. 87:(Suppl. 23):1994;19-21.
5. Crome, P., 1995. The Role of Elderly Volunteer Studies in Drug Development and Evaluation. A Thesis Submitted for the Degree of Doctor of Philosophy in the University of London.
6. Crome P. Clinical trials in the elderly. Good Clin. Pract. J. 8:2001;19-22.
7. Department of Health, 2001a. National Service Framework for Older People. Department of Health, London.
8. Department of Health, 2001b. Medicines and Older People. Implementing medicines-related aspects of the NSF for Older People. Department of Health.
9. Ford G.A. Pharmacodynamics. Crome P., Ford G. Drugs and the Older Population. 2000;90-108 Imperial College Press, London.
10. in T'Veld B.A., Ruitenbeg A., Hofman A., Launer L.J., van Duijn C.M., Stijen T., Breteler M.M.B., Stricker B.H.C. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. New Engl. J. Med. 345:2001;1515-1521.
11. Manesse C.K., Derkx F.H.M., de Ridder M.A.J., t'Veld A.J.M., van der Cammen T.J.M. Contribution of adverse drug reactions to hospital admission of older patients. Age Ageing. 29:2000;35-39.
12. Mohs R.C., Doody R.S., Morris J.C., Ieni J.R., Rogers S.L., Perdomo C.A., Pratt R.D. A 1-year, placebo controlled preservation of function survival study of donepezil in AD patients. Neurology. 57:2001;481-488.
13. O'Mahony S. Pharmacokinetics. Crome P., Ford G. Drugs and the Older Population. 2000;58-89 Imperial College Press, London.
14. O'Malley K., Crooks J., Duke E., Stephenson I.H. Effect of age and sex on human drug metabolism. Br. Med. J. 3:1971;607-609.
15. Powell C. Frailty: help or hindrance. J. R. Soc. Med. 90:(Suppl. 32):1997;23-26.
16. Rockwood K., Mitnitski A.B., MacKnight C. Some mathematical models of frailty and their clinical implications. Rev. Clin. Gerontol. 12:2002;109-117.
17. Roger S.L., Friedhoff L.T. The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study group. Dementia. 7:1996;292-303.
18. Thompson, S., Crome, P., 2002. Appropriate prescribing. Rev. Clin. Gerontol., 12.
19. Vestal R.E., Norris A.H., Tobin J.D., Cohen B.H., Shock N.W., Andres R. Antipyrine metabolism in man: influence of age, alcohol, caffeine and smoking. Clin. Pharmacol. Ther. 18:1975;425-432.
20. Williamson J., Chopin J.M. Adverse reactions to prescribed drugs in the elderly: a multicentre investigation. Age Ageing. 9:1980;73-80.